go back

Diphenhydramine, Oral

Hawaii rates for HCPCS Q0163

Diphenhydramine HCl, 50 mg, oral, FDA-approved prescription antiemetic, for use as a complete therapeutic substitute for an IV antiemetic at time of chemotherapy treatment not to exceed a 48-hour dosage regimen

Rates data updated July 2026.

Facilitymedian $3 · 10th–90th $3$30%50%100%$3Professionalmedian $0 · 10th–90th $0$00%50%90th$0$0.0$0.1$0.5$2.0$10.0$50.0$200.0

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$2.88
Median
$2.88
Typical High
$2.88
Aetna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.02
Cigna
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.33
HMSA
Setting
Professional
Modifier
Global
Typical Low
$0.28
Median
$0.28
Typical High
$0.28
Kaiser Permanente
Setting
Professional
Modifier
Global
Typical Low
$676.08
Median
$676.08
Typical High
$676.08
United
Setting
Professional
Modifier
Global
Typical Low
$0.02
Median
$0.02
Typical High
$0.28